A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease

Trial Identifier:	EFC18327
Sponsor:	Sanofi
Collaborator:	Teva Branded Pharmaceutical Products R&D LLC
Start Date:	January 2026
Primary Completion Date:	August 2029
Study Completion Date:	March 2034
Condition:	Crohn's Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.